(Q43517625)

English

Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years (English)

1 reference

Europe PubMed Central

24 November 2017

0 references

lung small cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Paesmans M

1

1 reference

Europe PubMed Central

24 November 2017

Sculier JP

2

1 reference

Europe PubMed Central

24 November 2017

Lecomte J

3

1 reference

Europe PubMed Central

24 November 2017

Thiriaux J

4

1 reference

Europe PubMed Central

24 November 2017

Libert P

5

1 reference

Europe PubMed Central

24 November 2017

Sergysels R

6

1 reference

Europe PubMed Central

24 November 2017

Bureau G

7

1 reference

Europe PubMed Central

24 November 2017

Dabouis G

8

1 reference

Europe PubMed Central

24 November 2017

Van Cutsem O

9

1 reference

Europe PubMed Central

24 November 2017

Mommen P

10

1 reference

Europe PubMed Central

24 November 2017

Ninane V

11

1 reference

Europe PubMed Central

24 November 2017

Klastersky J

12

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

89

1 reference

Europe PubMed Central

24 November 2017

523-533

1 reference

Europe PubMed Central

24 November 2017

3

1 reference

Europe PubMed Central

24 November 2017

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Chemotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Regression and recursive partition strategies in the analysis of medical survival data

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Small cell carcinoma of the lung. A progress report of 15 years' experience.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Long-term survival in small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Long-term survival in small cell lung cancer: the case for a standard definition. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Canc

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Pretreatment minimal staging and prognostic factors for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Prognostic factors and prognostic staging system for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Improvement and plateau in survival of small-cell lung cancer since 1975: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Long-term survival in small-cell carcinoma of the lung: a population experience

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Prognosis at presentation of small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000801%2989%3A3%3C523%3A%3AAID-CNCR7%3E3.0.CO%3B2-6

21 January 2018

Identifiers

10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43517625&oldid=1990332483"